Cite
Tang K, Si JK, Guo DD, et al. Ranibizumab alone or in combination with photodynamic therapy vs photodynamic therapy for polypoidal choroidal vasculopathy: a systematic review and Meta-analysis. Int J Ophthalmol. 2015;8(5):1056-66doi: 10.3980/j.issn.2222-3959.2015.05.36.
Tang, K., Si, J. K., Guo, D. D., Cui, Y., Du, Y. X., Pan, X. M., & Bi, H. S. (2015). Ranibizumab alone or in combination with photodynamic therapy vs photodynamic therapy for polypoidal choroidal vasculopathy: a systematic review and Meta-analysis. International journal of ophthalmology, 8(5), 1056-66. https://doi.org/10.3980/j.issn.2222-3959.2015.05.36
Tang, Kai, et al. "Ranibizumab alone or in combination with photodynamic therapy vs photodynamic therapy for polypoidal choroidal vasculopathy: a systematic review and Meta-analysis." International journal of ophthalmology vol. 8,5 (2015): 1056-66. doi: https://doi.org/10.3980/j.issn.2222-3959.2015.05.36
Tang K, Si JK, Guo DD, Cui Y, Du YX, Pan XM, Bi HS. Ranibizumab alone or in combination with photodynamic therapy vs photodynamic therapy for polypoidal choroidal vasculopathy: a systematic review and Meta-analysis. Int J Ophthalmol. 2015 Oct 18;8(5):1056-66. doi: 10.3980/j.issn.2222-3959.2015.05.36. eCollection 2015. PMID: 26558226; PMCID: PMC4630984.
Copy
Download .nbib